MISSION STATEMENT
Imaging & Therapy with Molecular and Radioactive Tracers
- promote nuclear medicine and molecular healthcare;
- lobby for appropriate regulations;
- push for innovation;
- support and facilitate logistics and operations
AIPES regularly coordinates its activities with CORAR and the Japanese industry association (JRPA)particularly on issues that relate to the international regulatory environment.
AIPES POSITION ON RADIOPHARMACEUTICALS
Three Pillars to Drive our Actions
1)PATIENTS SAFETY
- Full compliance: adoption of all relevant requirements, both on radioactivity and pharmaceuticals
- Compliance covers the entire process: from R&D, to manufacturing, to distribution, to any after sale events
2) INNOVATION
- Tradition of innovation and commitment to novel, future tracers
- Development of new drugs will require a more tailored regulatory approach
3) HEALTHCARE FOR EVERYONE
- Ensuring products and technology availability for millions of procedures all over Europe
AIPES CONTINUOUS OBJECTIVES
- Simplification of rules and procedures
- Harmonization through Europe
